Report #2844054

Received Jun 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Influenza like illness

Symptom narrative

felt more like he had case of flu; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of influenza in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza (Verbatim: felt more like he had case of flu). The outcome of the influenza was resolved (duration 36 hrs). It was unknown if the reporter considered the influenza to be related to Shingrix. It was unknown if the company considered the influenza to be related to Shingrix. Additional Information: GSK Receipt Date: 28-MAY-2025 Reporter stated that after receiving Shingrix they felt more like patient had a case of flu. This case is linked with case US2025AMR066426, reported by the same reporter.; Sender's Comments: US-GSK-US2025AMR066426:same reporter/female patient